Exploring possible mechanisms for COVID‐19 induced thrombocytopenia: Unanswered questions

A Amgalan, M Othman - Journal of Thrombosis and Haemostasis, 2020 - jthjournal.org
Dear Drs Lillicrap and Morrissey, We read with enthusiasm the recent article by Tang et al
entitled “Abnormal coagulation parameters are associated with poor prognosis in patients …

Coagulopathy associated with COVID-19

SG Lee, M Fralick, M Sholzberg - CMAJ, 2020 - Can Med Assoc
Coagulopathy correlates with severity of COVID-19 and may include increased d-dimer
concentrations (≥ 2 times above normal range), mildly prolonged prothrombin time (~ 1–3 s …

RE: ISTH interim guidance to recognition and management of coagulopathy in COVID‐19

S Akima, C McLintock, BJ Hunt - Journal of Thrombosis and …, 2020 - jthjournal.org
The unrelenting acceleration of COVID-19 infections due to SARS-CoV-2 is unquestionably
the greatest medical challenge of our professional careers. The Scientific and …

Coagulation dysfunction: a hallmark in COVID-19

Y Fei, N Tang, H Liu, W Cao - Archives of pathology & …, 2020 - meridian.allenpress.com
Context.—The coronavirus disease 2019 (COVID-19) is a highly contagious respiratory
disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …

Bleeding and bleeding risk in COVID-19

A Dorgalaleh - Seminars in thrombosis and hemostasis, 2020 - thieme-connect.com
Coronavirus disease 2019 (COVID-19) is a new, emerging medical challenge worldwide,
with those affected showing a variety of clinical presentations, ranging from asymptomatic or …

Pathological evidence of pulmonary thrombotic phenomena in severe COVID‐19

M Dolhnikoff, AN Duarte‐Neto… - Journal of Thrombosis …, 2020 - jthjournal.org
SARS-Cov-2 induces in severe cases a cytokine storm that ultimately leads to the activation
of coagulation cascade, causing thrombotic phenomena. 5 There is a further strong link …

COVID-19 coagulopathy, thrombosis, and bleeding

NC Chan, JI Weitz - Blood, The Journal of the American Society …, 2020 - ashpublications.org
United States alone. SARS-CoV-2 enters cells by binding to the angiotensinconverting
enzyme 2 receptor, which is expressed on respiratory epithelial cells and other cell types …

Covid-19-associated coagulopathy: biomarkers of thrombin generation and fibrinolysis leading the outcome

M Ranucci, C Sitzia, E Baryshnikova… - Journal of clinical …, 2020 - mdpi.com
Background: Coronavirus Disease 2019 (COVID-19)-associated coagulopathy is
characterized by a prothrombotic state not yet comprehensively studied. We investigated the …

The impact of COVID-19 disease on platelets and coagulation

GD Wool, JL Miller - Pathobiology, 2021 - karger.com
Abstract Coronavirus disease 2019 (COVID-19) causes a spectrum of disease; some
patients develop a severe proinflammatory state which can be associated with a unique …

COVID-19 and its implications for thrombosis and anticoagulation

JM Connors, JH Levy - Blood, The Journal of the American …, 2020 - ashpublications.org
Severe acute respiratory syndrome coronavirus 2, coronavirus disease 2019 (COVID-19)-
induced infection can be associated with a coagulopathy, findings consistent with infection …